Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

466 public trials 67 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Completed

Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension

NCT01613287

Conditions
Cardiovascular Diseases, Familial Primary Pulmonary Hypertension, Hypertension, +6 more
Locations
  • Thoraxklinik am Universitätsklinikum Heidelberg in cooperation with Nierenzentrum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Universitätsmedizin Greifswald, Zentrum für Innere Medizin, Klinik und Poliklinik für Innere Medizin B Greifswald, Mecklenburg-Vorpommern, Germany
  • Herzzentrum der Universität zu Köln, Klinik III für Innere Medizin und Zentrum für Molekulare Medizin Cologne, North Rhine-Westphalia, Germany
  • Deutsches Herzzentrum Berlin, Klinik für Herz-, Thorax- und Gefäßchirurgie Berlin, Germany
View Trial Details
Completed

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

NCT00781885

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Harbor-UCLA Medical Center Torrance, California, United States
  • Allegheny General Hospital Pittsburgh, Pennsylvania, United States
  • UTSW Medical Center Dallas, Texas, United States
  • Universite Libre de Bruxelles, Hospital Erasme Brussels, Belgium
View Trial Details
Completed

A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT03177603

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
  • GSK Investigational Site Dallas, Texas, United States
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Cologne, North Rhine-Westphalia, Germany
View Trial Details
Completed

Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy

NCT01560624

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • Arizona Pulmonary Specialists, Ltd. Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of California, San Francisco-Fresno Fresno, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 155 locations
View Trial Details

Related conditions